IMPACT OF DONOR DIVERSITY ON PHASE I AND PHASE II ACTIVITIES IN CRYOPRESERVED HUMAN HEPATOCYTES AND HUMAN LIVER MICROSOMES

被引：0
|
作者：
Bohl, Christopher [1 ]
Brouwer, Kenneth [2 ]
Heyward, Scott [3 ]
Cottier, Karissa [3 ]
Noah, Courtney [4 ]
Ogilvie, Brian [5 ]
机构：
[1] BioIVT, Kalamazoo, MI USA
[2] BioIVT, Durham, NC USA
[3] BioIVT, Baltimore, MD USA
[4] BioIVT, Hicksville, NY USA
[5] BioIVT, Kansas City, KS USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2024年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P27
引用
收藏
页数：2
相关论文
共 50 条
  • [41] DETERMINATION OF THE FRACTION METABOLISED BY PHASE II (UGT) ENZYMES USING HUMAN CRYOPRESERVED HEPATOCYTES AND 1-AMINOBENZO-TRIAZOLE (ABT)
    Kilford, Peter J.
    Stringer, Rowan
    Sohal, Bindi
    Houston, J. Brian
    Galetin, Aleksandra
    DRUG METABOLISM REVIEWS, 2007, 39 : 98 - 99
  • [42] Do cryopreserved sandwich cultured human hepatocytes better predict in-vivo CYP3A inactivation DDIs than human liver microsomes?
    Kirby, Brian J.
    Grepper, Susan
    Unadkat, Jashvant D.
    DRUG METABOLISM REVIEWS, 2011, 43 : 32 - 32
  • [43] PRESENCE OF PHASE-I AND PHASE-II DRUG-METABOLIZING-ENZYMES IN CULTURED HUMAN-FETAL HEPATOCYTES
    GUILLOUZO, A
    LEBIGOT, JF
    GUGUENGUILLOUZO, C
    KIECHEL, JR
    BIOCHEMICAL PHARMACOLOGY, 1982, 31 (14) : 2427 - 2430
  • [44] Effect of chromium and cobalt ions on phase I and phase Ii enzymatic activities in freshly isolated rat hepatocytes
    Afolaranmi, Grace A.
    Henderson, Catherine
    Grant, M. Helen
    TOXICOLOGY, 2010, 278 (03) : 367 - 367
  • [45] Determination of piceatannol in rat serum and liver microsomes: pharmacokinetics and phase I and II biotransformation
    Roupe, K
    Teng, XW
    Fu, X
    Meadows, GG
    Davies, NM
    BIOMEDICAL CHROMATOGRAPHY, 2004, 18 (08) : 486 - 491
  • [46] Long-Term Stability of Cryopreserved Human Hepatocytes: Evaluation of Phase I and II Drug-Metabolizing Enzyme Activities and CYP3A4/5 Induction for More than a Decade
    Sudo, Miyako
    Nishihara, Mitsuhiro
    Takahashi, Junzo
    Asahi, Satoru
    DRUG METABOLISM AND DISPOSITION, 2017, 45 (07) : 734 - 736
  • [47] Species comparison of in vitro reduction of benzamidoxime to benzamidine in liver microsomes and cryopreserved hepatocytes from rat, monkey, dog, pig, and human
    Liu, L
    Ling, Y
    Ginn, E
    Sukbuntherng, J
    Young, W
    Mordenti, J
    DRUG METABOLISM REVIEWS, 2004, 36 : 201 - 201
  • [48] Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride
    Teichert, Jens
    Baumann, Frank
    Chao, Qi
    Franklin, Craig
    Bailey, Brandy
    Hennig, Lothar
    Caca, Karel
    Schoppmeyer, Konrad
    Patzak, Ulrich
    Preiss, Rainer
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (06) : 759 - 770
  • [49] Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride
    Jens Teichert
    Frank Baumann
    Qi Chao
    Craig Franklin
    Brandy Bailey
    Lothar Hennig
    Karel Caca
    Konrad Schoppmeyer
    Ulrich Patzak
    Rainer Preiss
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 759 - 770
  • [50] Coordinated induction of drug transporters and phase I and II metabolism in human liver slices
    Olinga, P.
    Elferink, M. G. L.
    Draaisma, A. L.
    Merema, M.
    Castell, J. V.
    Perez, G.
    Groothuis, G. M. M.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 33 (4-5) : 380 - 389
12345